HARMONY
Report
- Report Number
- 3004167969-2018-00012
- Event Type
- Injury
- Date Received
- December 11, 2018
- Date of Event
- November 8, 2018
- Report Date
- November 12, 2018
- Manufacturer
- ALMA LASERS LTD
- Product Code
- GEX
- UDI-DI
- 17290110120433
- PMA / PMN Number
- K072564
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- 501
Narratives
EXEMPTION LETTER E2013012 ALMA LTD. (MANUFACTURER) IS SUBMITTING THE REPORT ON BEHALF OF ALMA, INC. (IMPORTER). ALMA INC. (IMPORTER) HAS EVALUATED THE HANDPIECE AND FOUND THAT IT MEETS MANUFACTURER'S SPECIFICATIONS. THE SYSTEM WAS ALSO INSPECTED AND IT WAS FOUND THAT IT HAD A DAMAGED HANDPIECE CONNECTOR. THE DAMAGED HANDPIECE CONNECTOR IS NOT LIKELY TO CONTRIBUTE TO THE ADVERSE EVENT AS THE SYSTEM CANNOT BE OPERATED IN THIS CONDITION. IT APPEARS THAT THE DAMAGE TO THE HANDPIECE CONNECTOR MAY HAVE OCCURRED DURING THE TRANSIT BACK TO ALMA. PER THE FACILITY, PATIENT BURNS WERE DIAGNOSED AS SECOND AND THIRD DEGREE BURNS. AT THIS TIME NO NEW PHOTOGRAPHS OR INFORMATION IS AVAILABLE TO ASSESS THE PATIENT SKIN CONDITION. THEREFORE, ALMA LASERS IS SUBMITTING THE REPORT TO FDA IN GOOD FAITH EFFORTS. BASED ON THE INFORMATION AVAILABLE, ALMA LASERS LTD. CLINICAL DETERMINED THAT FAILURE TO PERFORM SKIN TEST AND THE NUMBER OF PULSES ADMINISTERED FOR THE PATIENT'S SKIN CONDITION WERE LIKELY EXCESSIVE CONTRIBUTING TOWARDS THIS UNTOWARD SKIN REACTION.
THE SUSPECTED DEVICE WAS USED ON PATIENT'S LEGS BILATERALLY FOR BENIGN PIGMENTED LESIONS. THE FACILITY PROVIDED THE PATIENT WITH BIAFINE TOPICAL EMULSION AND 800 MG IBUPROFEN AS POST-TREATMENT CARE. PER THE FACILITY, THE PATIENT WAS SEEING A WOUND CARE SPECIALIST AS AN OUT-PATIENT INITIALLY BUT WAS LATER ADMITTED AS AN IN-PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 992983 | HARMONY | MEDICAL LASER | GEX | ALMA LASERS LTD | 540 VL/PL | 17290110120433 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Hospitalization |